Generics - India, Markets & Marketing

Filter

Current filters:

IndiaMarkets & Marketing

Popular Filters

India takes action on spurious and sub-standard drugs

India takes action on spurious and sub-standard drugs

10-11-2014

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals…

GenericsIndiaMarkets & MarketingPharmaceuticalPoliticsRegulation

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

Indian pharma envisages exports expansion, including in Latin American

Indian pharma envisages exports expansion, including in Latin American

16-09-2014

India Brand Equity Foundation (IBEF) today announced the sustained collective efforts being made by the…

FinancialGenericsIndiaMarkets & MarketingPatentsSouth America

Alchem International commits to tropane alkaloid APIs to resolve supply gap

15-09-2014

Following the decision by the principal European manufacturers to exit or end market development and…

Alchem InternationalGenericsIndiaMarkets & MarketingProductiontropane alkaloid

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

01-09-2014

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo…

AdvairCiplaGenericsIndiaMarkets & MarketingRespiratory and Pulmonary

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

India’s Lupin launches insulin glargine analogue Basugine

11-08-2014

Indian generic drugmaker Lupin has entered into a strategic distribution agreement with LG Life Sciences…

BasugineBiosimilarsDiabetesGenericsIndiaLantusLG Life SciencesLupinMarkets & MarketingPeptide hormonesRecombinant proteinsSanofi

Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen

30-06-2014

Cipla has collaborated with fellow Indian drugmaker Hetero to launch a biosimilar of the drug darbepoetin…

ActoriseAmgenAranespBiosimilarsCiplaGenericsHeteroIndiaMarkets & MarketingMergers & AcquisitionsOncologyRest of the World

Intas reinforces cancer range with the first time launch of Azadine in India

25-06-2014

Indian drugmaker Intas Pharmaceuticals says it has reinforced its oncology product range by successfully…

AzadineCelgeneGenericsIndiaIntas PharmaceuticalsMarkets & MarketingOncologyVidaza

Indian govt plans to support a competitive pharma sector, especially for SMEs

Indian govt plans to support a competitive pharma sector, especially for SMEs

14-04-2014

In a bid to strengthen the existing infrastructure facilities and to enable the Indian pharmaceutical…

Asia-PacificGenericsIndiaMarkets & MarketingPoliticsProduction

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

Mylan debuts Hertraz, first Herceptin biosimilar, in India

Mylan debuts Hertraz, first Herceptin biosimilar, in India

03-02-2014

US generics major Mylan has launched the world's first trastuzumab biosimilar in India. The product,…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazIndiaMarkets & MarketingMylan LaboratoriesOncologyRoche

COMPANY SPOTLIGHT

Menarini

Back to top